ORA
Commercial- Indications
- Infertility
Company intelligence / Profile preview
Inti Labs offers commercial-stage diagnostic products for fertility clinics and IVF patients. Their flagship product ora® provides non-invasive endometrial receptivity testing using microRNA biomarkers from blood samples to optimize embryo transfer timing. Other products include OPAL for egg quality evaluation and Embryo46 for advanced preimplantation genetic screening. Clinical results highlight improved IVF outcomes with fewer cycles required[1][8].
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inti Labs.